Jafron Biomedical Co Ltd (300529) — Cash Flow Quality Index
Jafron Biomedical Co Ltd (300529) has a Cash Flow Quality Index of 0.56x as of September 2025. Operating cash flow of CN¥35.34 Million is below net income of CN¥63.51 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Jafron Biomedical Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jafron Biomedical Co Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Jafron Biomedical Co Ltd across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300529 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jafron Biomedical Co Ltd (2011–2025)
Year-by-year earnings quality comparison for Jafron Biomedical Co Ltd. For live market cap and the full company financial profile, see 300529 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | CN¥721.22 Million | CN¥532.82 Million | ▲ +5.6% |
| 2024 | 1.28x | CN¥1.05 Billion | CN¥820.20 Million | ▼ -40.5% |
| 2023 | 2.15x | CN¥916.74 Million | CN¥425.72 Million | ▲ +114.6% |
| 2022 | 1.00x | CN¥883.80 Million | CN¥880.92 Million | ▼ -4.0% |
| 2021 | 1.04x | CN¥1.25 Billion | CN¥1.20 Billion | ▼ -4.7% |
| 2020 | 1.10x | CN¥957.49 Million | CN¥873.00 Million | ▲ +6.9% |
| 2019 | 1.03x | CN¥583.50 Million | CN¥568.69 Million | ▲ +7.1% |
| 2018 | 0.96x | CN¥384.08 Million | CN¥400.95 Million | ▼ -10.4% |
| 2017 | 1.07x | CN¥304.10 Million | CN¥284.45 Million | ▲ +21.0% |
| 2016 | 0.88x | CN¥178.64 Million | CN¥202.12 Million | ▼ -13.7% |
| 2015 | 1.02x | CN¥205.18 Million | CN¥200.44 Million | ▲ +19.3% |
| 2014 | 0.86x | CN¥137.35 Million | CN¥160.05 Million | ▼ -18.4% |
| 2013 | 1.05x | CN¥133.33 Million | CN¥126.78 Million | ▼ -12.5% |
| 2012 | 1.20x | CN¥120.25 Million | CN¥100.02 Million | ▲ +18.2% |
| 2011 | 1.02x | CN¥77.06 Million | CN¥75.76 Million | — |